The Pharmaceutical Primary Packaging Labels Market will generate a substantial increase in opportunities from 2021 to 2030

0

Pharmaceutical Primary Packaging Labels Market 23

Pharmaceutical Primary Packaging Labels Market was valued at USD 2,377.83 Million in 2020 and is projected to reach USD 4,762.81 Million by 2030, registering a CAGR of 7.20%

PORTLAND, OREGON, USA, Sept. 5, 2022 /EINPresswire.com/ — The global pharmaceutical primary packaging label market size was valued at $2,377.83 million in 2020 and is expected to reach $4,762.81 million by 2030, registering a CAGR of 7.20% from 2021 to 2030.

Rising instances of counterfeiting, rise in manufacturing of recyclable and biodegradable labeling products, and adoption of expanded content label design are driving the growth of the global pharmaceutical primary packaging label market. However, strict government regulations and standards limit the market growth. On the other hand, the use of smart labeling for patient engagement and identification will create new opportunities in the coming years.

Get sample report at: https://www.alliedmarketresearch.com/request-sample/15786

increasing cases of counterfeiting and increasing manufacturing of recyclable and biodegradable label products, increasing adoption of expanded content label design and increasing demand for cryogenic labels During the COVID-19 are few factors that are expected to propel the growth of the Pharmaceutical Primary Packaging Labels Market during the forecast period. Additionally, growth in the use of smart tagging for patient engagement and identification is expected to provide profitable opportunities for market growth over the forecast period.

The major factors influencing the growth of the pharmaceutical primary packaging label market include increasing instances of counterfeiting and increasing manufacturing of recyclable and biodegradable label products. Additionally, increasing adoption of expanded content label design and rise in demand for cryogenic labels during COVID-19 is also driving the market growth. However, stringent regulations and standards act as barriers for new entrants and hinder the growth of the Pharmaceutical Primary Packaging Labels market. On the other hand, growth in the use of smart labeling for patient engagement and identification is expected to provide profitable opportunities for market growth over the forecast period.

Covid-19 scenario

The Covid-19 pandemic has disrupted workflows in healthcare subareas and pharmaceutical packaging labeling is one of the markets affected in the early stages of the pandemic in 2020.

The demand for pharmaceutical primary packaging labels has increased during the Covid-19 pandemic with the rise in adoption of expanded content label design and demand for cryogenic labels for proper storage or transportation vaccines in incredibly cold temperatures.

Pharmaceutical label makers have launched technologically advanced products to speed up the packaging and supply of Covid-19 vaccines.

Main results of the study

By primary packaging containers, the prescription primary container segment held the largest share of the global pharmaceutical primary packaging label market in 2020.

By face material, the film segment held the largest market share in 2020 and is expected to remain dominant throughout the forecast period.

By type of adhesive technology, acrylic solvent segment led the global pharmaceutical primary packaging label market in 2020 and is expected to continue this trend during the forecast period.

By storage type, the cryogenic and refrigerated storage product segment held the largest market share in 2020 and is expected to continue this trend during the forecast period.

Regionally, North America is expected to witness the highest growth rate, registering a CAGR of 7.10% during the forecast period.

Do you have a specific question or requirement? Ask our industry expert: https://www.alliedmarketresearch.com/purchase-enquiry/15786

The segment of cryogenic and refrigerated storage products to maintain its leading position by 2030

Based on storage type, the cryogenic and refrigerated storage products segment held the highest share in 2020, accounting for more than half of the global pharmaceutical primary packaging label market, and is expected to maintain its leading position throughout throughout the forecast period. Additionally, this segment is estimated to witness the fastest CAGR of 7.4% from 2021 to 2030. cryogenic and refrigerated storage products. The research also analyzes the segment of non-refrigerated storage products.

North America will maintain its revenue dominance by 2030

Based on region, North America contributed the largest market share in 2020, accounting for approximately two-fifths of the global pharmaceutical primary packaging label market, and is expected to maintain its dominance in terms of pharmaceutical primary packaging label revenue. by 2030. This is attributed to a well-established healthcare system that requires proper labeling of pharmaceutical primary packaging and strict rules and regulations. However, LAMEA is expected to experience the fastest CAGR of 8.0% during the forecast period. This is due to increased health and pharmaceutical spending by governments in the region.

Main market players

Avery Dennison Company
CCL Industries
Consolidated Label Co.
Essentra Plc.
Herma GmbH
Lintec Corporation
MCC label
ProMach
The 3M company
UPM

We also offer regional and national reports –

Japan Pharmaceutical Primary Packaging Label Market
South Korea Pharmaceutical Primary Packaging Label Market
Singapore Pharmaceutical Primary Packaging Label Market
China pharmaceutical primary packaging label market
Indonesia Pharmaceutical Primary Packaging Labels Market
Australian Pharmaceutical Primary Packaging Labels Market
Taiwan Pharmaceutical Primary Packaging Label Market

“We have also published some syndicated market studies in the same field that you may be interested in. Below is the title of the report for your reference, considering the impact of Covid-19 on this market, which will help you to assess the impact of the pandemic on the short and long-term growth trends of this market.

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business consulting division of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global corporations as well as small and medium enterprises with unrivaled quality of “market research reports” and “Business Intelligence solutions”. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market areas. AMR offers its services across 11 verticals, including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverage, Energy & Power, semiconductors and electronics, automotive and transport, ICT and media, aerospace and defense and BFSI.

David Correa
Allied Analytics LLP
800-792-5285
write to us here
Visit us on social media:
Facebook
Twitter
LinkedIn



Source link

Share.

About Author

Comments are closed.